Healthcare -
Biotechnology - NASDAQ - US
$ 6.385
3.15 %
$ 286 M
Market Cap
-11.82
P/E
YMAB - PRE-TAX INCOME
Pre-tax Income YMAB - Y-mAbs Therapeutics, Inc.
-20.9 M
LAST VALUE
38.56%
2 YEAR CAGR
13.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR